Carr, David JWallace, Jacqueline MAitken, Raymond PMilne, John SMartin, John F.Zachary, Ian C.Peebles, Donald M.David, Anna L2019-09-182019-09-182016-06-01Carr, D J, Wallace, J M, Aitken, R P, Milne, J S, Martin, J F, Zachary, I C, Peebles, D M & David, A L 2016, 'Peri- and postnatal effects of prenatal adenoviral VEGF gene therapy in growth-restricted sheep', Biology of Reproduction, vol. 94, no. 6, 142. https://doi.org/10.1095/biolreprod.115.1337440006-3363ORCID: /0000-0003-3099-5902/work/76975214http://hdl.handle.net/2164/12958Supported by Wellcome Trust project grant 088208 to A.L.D., J.M.W., D.M.P., I.C.Z., and J.F.M. Wellbeing of Women research training fellowship 318 to D.J.C., Scottish Government work package 4.2 to J.M.W., J.S.M., and R.P.A., as well as funding from the National Institute for Health Research University College London Hospitals Biomedical Research Centre A.L.D. and D.M.P., the British Heart Foundation to I.C.Z., and Ark Therapeutics Oy, Kuopio, Finland, which supplied adenovirus vectors free of charge.546162engIntrauterine growth restriction (IUGR)gene therapymetabolismsheepvascular endothelial growth factorQP PhysiologyWellcome Trust088208QPJournal article10.1095/biolreprod.115.133744https://bioone.org/journals/Biology-of-Reproduction/volume-94/issue-6/biolreprod.115.133744/Peri--and-Postnatal-Effects-of-Prenatal-Adenoviral-VEGF-Gene/10.1095/biolreprod.115.133744.full946